225 related articles for article (PubMed ID: 22500958)
21. Non-medical exposure to radioiodines and thyroid cancer.
Hindié E; Leenhardt L; Vitaux F; Colas-Linhart N; Grosclaude P; Galle P; Aurengo A; Bok B
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S497-512. PubMed ID: 12192552
[TBL] [Abstract][Full Text] [Related]
22. Iodine prophylaxis and nuclear accidents.
Franić Z
Arh Hig Rada Toksikol; 1999 Jun; 50(2):223-33. PubMed ID: 10566200
[TBL] [Abstract][Full Text] [Related]
23. [Biological effects and risks of accidental radionuclide uptake].
Fueger GF
Acta Med Austriaca; 1986; 13(4-5):86-93. PubMed ID: 3554876
[TBL] [Abstract][Full Text] [Related]
24. [Prophylaxis of radiation-induced thyroid cancers in children after the reactor catastrophy of Chernobyl].
Reiners C
Nuklearmedizin; 1994 Dec; 33(6):229-34. PubMed ID: 7854918
[TBL] [Abstract][Full Text] [Related]
25. [Thyroid cancer after Chernobyl: is iodine 131 the only culprit ? Impact on clinical practice].
Guiraud-Vitaux F; Elbast M; Colas-Linhart N; Hindie E
Bull Cancer; 2008 Feb; 95(2):191-5. PubMed ID: 18304904
[TBL] [Abstract][Full Text] [Related]
26. Re: Risk of thyroid cancer after exposure to (131)I in childhood.
Grossman CM; Nussbaum RH
J Natl Cancer Inst; 2006 May; 98(9):641; author reply 641-2. PubMed ID: 16670390
[No Abstract] [Full Text] [Related]
27. DO MULTIPLE ADMINISTRATIONS OF STABLE IODINE PROTECT POPULATION CHRONICALLY EXPOSED TO RADIOACTIVE IODINE: WHAT IS PRIODAC RESEARCH PROGRAM (2014-22) TEACHING US?
Benderitter M; Pourcher T; Martin JC; Darcourt J; Guigon P; Caire-Maurisier F; Pech A; Lebsir D; Rosique C; Guglielmi J; Rebière F; Tack K; Phan G; Lestaevel P; Souidi M; Jourdain JR
Radiat Prot Dosimetry; 2018 Dec; 182(1):67-79. PubMed ID: 30169846
[TBL] [Abstract][Full Text] [Related]
28.
Calcaterra V; Mameli C; Rossi V; Massini G; Gambino M; Baldassarre P; Zuccotti G
Front Endocrinol (Lausanne); 2022; 13():901620. PubMed ID: 35692388
[TBL] [Abstract][Full Text] [Related]
29. Potassium iodide for thyroid protection in a nuclear accident or attack.
Med Lett Drugs Ther; 2002 Nov; 44(1143):97-8. PubMed ID: 12492101
[No Abstract] [Full Text] [Related]
30. Risks in mass distribution of potassium iodide.
Yalow RS
Bull N Y Acad Med; 1983 Dec; 59(10):1020-7. PubMed ID: 6582963
[No Abstract] [Full Text] [Related]
31. [Radiation exposure and thyroid cancer].
Cannizzaro MA; Veroux M; Costanzo M; Buffone A; Okatyeva V
Ann Ital Chir; 2012; 83(5):369-72. PubMed ID: 23064295
[TBL] [Abstract][Full Text] [Related]
32. Age-dependent potassium iodide effect on the thyroid irradiation by 131I and 133I in the nuclear emergency.
Jang M; Kim HK; Choi CW; Kang CS
Radiat Prot Dosimetry; 2008; 130(4):499-502. PubMed ID: 18337292
[TBL] [Abstract][Full Text] [Related]
33. France distributes iodine near reactors.
Balter M
Science; 1997 Mar; 275(5308):1871-2. PubMed ID: 9122686
[No Abstract] [Full Text] [Related]
34. [Protection of the thyroid in children and fetuses in case of nuclear accident].
Vernis M; Hindie E; Galle P
Arch Pediatr; 1997 May; 4(5):473-9. PubMed ID: 9230999
[TBL] [Abstract][Full Text] [Related]
35. Thyroid dose estimation with potassium iodide (KI) administration in a nuclear emergency.
Jang M; Kim HK; Choi CW; Kang CS
Radiat Prot Dosimetry; 2008; 132(3):303-7. PubMed ID: 19054795
[TBL] [Abstract][Full Text] [Related]
36. Re: Risk of thyroid cancer after exposure to (131)I in childhood.
Scott BR
J Natl Cancer Inst; 2006 Apr; 98(8):561; author reply 561. PubMed ID: 16622126
[No Abstract] [Full Text] [Related]
37. Issues and epidemiological evidence regarding radiation-induced thyroid cancer.
Shore RE
Radiat Res; 1992 Jul; 131(1):98-111. PubMed ID: 1385649
[TBL] [Abstract][Full Text] [Related]
38. Iodine nutrition and the risk from radioactive iodine: a workshop report in the chernobyl long-term follow-up study.
Robbins J; Dunn JT; Bouville A; Kravchenko VI; Lubin J; Petrenko S; Sullivan KM; Vanmiddlesworth L; Wolff J
Thyroid; 2001 May; 11(5):487-91. PubMed ID: 11396707
[TBL] [Abstract][Full Text] [Related]
39. Suppression of thyroid radioiodine uptake by various doses of stable iodide.
Sternthal E; Lipworth L; Stanley B; Abreau C; Fang SL; Braverman LE
N Engl J Med; 1980 Nov; 303(19):1083-8. PubMed ID: 7421914
[TBL] [Abstract][Full Text] [Related]
40. Physiological basis for the use of potassium iodide as a thyroid blocking agent logistic issues in its distribution.
Becker DV
Bull N Y Acad Med; 1983 Dec; 59(10):1003-8. PubMed ID: 6582961
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
